Optimizing Acitretin Monitoring and Discontinuation: A Multicenter Retrospective Study on Laboratory Abnormalities, Adverse Effects, and Post-Treatment Cutaneous Squamous Cell Carcinoma Risk

Published: 5 March 2026| Version 1 | DOI: 10.17632/yr759ptzgw.1
Contributor:
Bina Kassamali

Description

Enclosed are supplementary tables and materials for the article titled "Optimizing Acitretin Monitoring and Discontinuation: A Multicenter Retrospective Study on Laboratory Abnormalities, Adverse Effects, and Post-Treatment Cutaneous Squamous Cell Carcinoma Risk." Supplementary Table I: Demographics Supplementary Table II: Lab abnormalities versus clinically significant lab abnormalities Supplementary Materials and Methods

Files

Categories

Skin Cancer, Demographics, Descriptive Table

Licence